States Are Pressuring the DEA for Answers | TTB Presented by Flowhub
TDR
6,992 views
In our latest Trade to Black podcast, presented by Flowhub, hosts Shadd Dales and Anthony Varrell kick off the week with news from one of the largest cannabis companies in the U.S. Trulieve (NYSE: TRLV) announced an exclusive master licensing agreement with Connected for the rights to genetics, trademarks, and proprietary know-how to produce and sell Alien Labs and Connected branded cannabis products in Florida and Texas.
Trulieve has been the exclusive provider of both brands in Florida since 2022, and this deal locks that in under a perpetual, royalty-free license. Connected founder Caleb Counts calls it one of the most successful brand licensing relationships in cannabis, built on genetics from Connected's proprietary breeding program.
Trulieve plans to add new product categories and form factors in Florida, introduce both brands in Texas pending final licensure and regulatory approvals, and has the opportunity to negotiate rights in additional expansion markets.
In segment two, Michael Bronstein, President of the American Trade Association for Cannabis and Hemp, joins for his weekly Insiders Edge segment.
They start in Pennsylvania, where House Speaker Joanna McClinton says adult-use legalization could happen next year if Democrats flip three State Senate seats in November, with the governor's race adding a second variable.
They then get into the pressure state officials are putting on the DEA for clearer communication on how the Schedule III medical framework is supposed to work. The Cannabis Regulators Association and California's top cannabis regulator both say federal guidance is missing, with open questions on dual-license registration, caregivers, and inconsistent answers from regional DEA offices.
That leads to whether Attorney General Todd Blanche should issue a memo laying out the national framework once rescheduling is finalized.
00:00:00 Intro and MSOS price action
00:02:42 Why you should be patient on the ALJ ruling
00:03:20 Psychedelics: Compass, MAPS and Lykos
00:06:05 Trulieve licenses Alien Labs and Connected
00:09:29 Why Texas medical will be a slow start
00:10:11 Pennsylvania Hemp and Cannabinoid Act
00:15:50 Michael Bronstein joins
00:24:38 Unregulated smoke shops and hemp risks
00:28:43 Can Democrats flip the PA Senate and legalize?
00:41:51 DEA is silent with state regulators
00:48:34 Why Schedule III won't be a simple fit
01:03:35 Glass House Brands valuation
#TradeToBlack #Trulieve #AlienLabs #CannabisRescheduling #ScheduleIII #DEA #Pennsylvania #CannabisNews #Texas #Flowhub #TrumpAdministration #CannabisStocks #CannabisIndustry
Want to see last week's recap?
🎬 Trulieve, Curaleaf Land Major Index Wins |...
Want to see more Cannabis Reform?
🎬 Cannabis Rescheduling's Next Step: Making ...
🎬 Three Senate Seats Could Legalize Cannabis...
🎬 Paxton's Alcohol Ties Raise Real Questions...
Want to stay updated on Cannabis, Small Cap, AI, and Crypto?
Subscribe to our Daily Baked newsletter:
https://newsletter.thedalesreport.com...
Find us on social media and podcast platforms:
✅ Facebook: Facebook: TheDalesReport
✅ Twitter: Twitter: TheDalesReport
✅ Instagram: Instagram: dalesreport
✅ LinkedIn: LinkedIn: the-dales-report
Apple Podcasts: https://tinyurl.com/TDRTradetoBlackon...
Spotify: https://tinyurl.com/TDRTradeToBlackon...
Website: https://thedalesreport.com/
For copyright matters, contact:
sdales@thedalesreport.com
Podcast Disclaimer (Financial Interests)
The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.
The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.
By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions made based on the information discussed.
Full Disclosures: https://thedalesreport.com/website-te...
16 Comments
States Are Pressuring the DEA for Answers | TTB Presented by Flowhub
TDR
6,992 views
In our latest Trade to Black podcast, presented by Flowhub, hosts Shadd Dales and Anthony Varrell kick off the week with news from one of the largest cannabis companies in the U.S. Trulieve (NYSE: TRLV) announced an exclusive master licensing agreement with Connected for the rights to genetics, trademarks, and proprietary know-how to produce and sell Alien Labs and Connected branded cannabis products in Florida and Texas.
Trulieve has been the exclusive provider of both brands in Florida since 2022, and this deal locks that in under a perpetual, royalty-free license. Connected founder Caleb Counts calls it one of the most successful brand licensing relationships in cannabis, built on genetics from Connected's proprietary breeding program.
Trulieve plans to add new product categories and form factors in Florida, introduce both brands in Texas pending final licensure and regulatory approvals, and has the opportunity to negotiate rights in additional expansion markets.
In segment two, Michael Bronstein, President of the American Trade Association for Cannabis and Hemp, joins for his weekly Insiders Edge segment.
They start in Pennsylvania, where House Speaker Joanna McClinton says adult-use legalization could happen next year if Democrats flip three State Senate seats in November, with the governor's race adding a second variable.
They then get into the pressure state officials are putting on the DEA for clearer communication on how the Schedule III medical framework is supposed to work. The Cannabis Regulators Association and California's top cannabis regulator both say federal guidance is missing, with open questions on dual-license registration, caregivers, and inconsistent answers from regional DEA offices.
That leads to whether Attorney General Todd Blanche should issue a memo laying out the national framework once rescheduling is finalized.
00:00:00 Intro and MSOS price action
00:02:42 Why you should be patient on the ALJ ruling
00:03:20 Psychedelics: Compass, MAPS and Lykos
00:06:05 Trulieve licenses Alien Labs and Connected
00:09:29 Why Texas medical will be a slow start
00:10:11 Pennsylvania Hemp and Cannabinoid Act
00:15:50 Michael Bronstein joins
00:24:38 Unregulated smoke shops and hemp risks
00:28:43 Can Democrats flip the PA Senate and legalize?
00:41:51 DEA is silent with state regulators
00:48:34 Why Schedule III won't be a simple fit
01:03:35 Glass House Brands valuation
#TradeToBlack #Trulieve #AlienLabs #CannabisRescheduling #ScheduleIII #DEA #Pennsylvania #CannabisNews #Texas #Flowhub #TrumpAdministration #CannabisStocks #CannabisIndustry
Want to see last week's recap?
🎬 Trulieve, Curaleaf Land Major Index Wins |...
Want to see more Cannabis Reform?
🎬 Cannabis Rescheduling's Next Step: Making ...
🎬 Three Senate Seats Could Legalize Cannabis...
🎬 Paxton's Alcohol Ties Raise Real Questions...
Want to stay updated on Cannabis, Small Cap, AI, and Crypto?
Subscribe to our Daily Baked newsletter:
https://newsletter.thedalesreport.com...
Find us on social media and podcast platforms:
✅ Facebook: Facebook: TheDalesReport
✅ Twitter: Twitter: TheDalesReport
✅ Instagram: Instagram: dalesreport
✅ LinkedIn: LinkedIn: the-dales-report
Apple Podcasts: https://tinyurl.com/TDRTradetoBlackon...
Spotify: https://tinyurl.com/TDRTradeToBlackon...
Website: https://thedalesreport.com/
For copyright matters, contact:
sdales@thedalesreport.com
Podcast Disclaimer (Financial Interests)
The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.
The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.
By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions made based on the information discussed.
Full Disclosures: https://thedalesreport.com/website-te...